Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins and screening methods for modulators

Details for Australian Patent Application No. 2001239884 (hide)

International Classifications

Event Publications

13 March 2003 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee to Ludwig Institute for Cancer Research and Licentia Ltd.

10 August 2006 Application Accepted

Published as AU-B-2001239884

7 December 2006 Standard Patent Sealed

14 June 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 24 May 2007. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 2002

18 October 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 24 May 2007

7 August 2008 Assignment Registered

Ludwig Institute for Cancer Research; Licentia Ltd The patent has been assigned to Vegenics Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.